THCH(THCH)
THCH
No analyst ratings available
No analyst price targets available for THCH
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.18B | $1.39B |
| Low | $1.18B | $1.39B |
| High | $1.18B | $1.39B |
| EBITDA Avg | $-109M | $-10M |
| Low | $-109M | $-10M |
| High | $-109M | $-10M |
| EBIT Avg | $-248M | $-186M |
| Low | $-248M | $-186M |
| High | $-248M | $-186M |
| Net Income Avg | $-268M | $-205M |
| Low | $-268M | $-205M |
| High | $-268M | $-205M |
| EPS Avg | $-8.23 | $-6.32 |
| Low | $-8.23 | $-6.32 |
| High | $-8.23 | $-6.32 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $315M | $320M | $292M | $339M | $378M | $383M |
| Low | $315M | $320M | $292M | $339M | $378M | $383M |
| High | $315M | $320M | $292M | $339M | $378M | $383M |
| EBITDA Avg | $-25M | $-20M | $-32M | $-19M | $-5M | $-7M |
| Low | $-25M | $-20M | $-32M | $-19M | $-5M | $-7M |
| High | $-25M | $-20M | $-32M | $-19M | $-5M | $-7M |
| EBIT Avg | $-48M | $-45M | $-60M | $-49M | $-38M | $-43M |
| Low | $-48M | $-45M | $-60M | $-49M | $-38M | $-43M |
| High | $-48M | $-45M | $-60M | $-49M | $-38M | $-43M |
| Net Income Avg | $-52M | $-49M | $-64M | $-53M | $-42M | $-47M |
| Low | $-52M | $-49M | $-64M | $-53M | $-42M | $-47M |
| High | $-52M | $-49M | $-64M | $-53M | $-42M | $-47M |
| EPS Avg | $-1.60 | $-1.51 | $-1.97 | $-1.62 | $-1.29 | $-1.43 |
| Low | $-1.60 | $-1.51 | $-1.97 | $-1.62 | $-1.29 | $-1.43 |
| High | $-1.60 | $-1.51 | $-1.97 | $-1.62 | $-1.29 | $-1.43 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |